Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Bantel

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Gut|January 22, 2018
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implicationHeike Bantel, Ali Canbay
Innere Medizin (Heidelberg, Germany)|May 8, 2024
[Drug treatment of non-alcoholic steatohepatitis : MAESTRO-NASH]Heike Bantel, Sirka Nitschmann
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can cell death biomarkers predict the outcome of acute liver failure?Heike Bantel, Klaus Schulze-Osthoff
Hepatology (Baltimore, Md.)|March 5, 2011
Necrosis versus apoptosis in acetaminophen-induced hepatotoxicityKlaus Schulze-Osthoff, Heike Bantel
Inflammatory Bowel Diseases|April 27, 2012
TNF Antagonists in IBD: Novel Antiinflammatory Mechanisms Beyond Cytokine InhibitionHeike Bantel, Klaus Schulze-Osthoff
Journal of Hepatology|August 25, 2022
Non-invasive tests for evaluating treatment response in NAFLDHeike Bantel, Klaus Schulze-Osthoff
The FEBS Journal|December 19, 2017
Macrophage p38 kinase inhibition for liver regenerationKlaus Schulze-Osthoff, Heike Bantel
Critical Care (London, England)|August 15, 2009
Cell death in sepsis: a matter of how, when, and whereHeike Bantel, Klaus Schulze-Osthoff
Frontiers in Physiology|April 10, 2012
Mechanisms of cell death in acute liver failureHeike Bantel, Klaus Schulze-Osthoff
Cell Cycle (Georgetown, Tex.)|August 3, 2010
DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondriaHeike Bantel, Hans-Uwe Simon
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Gut|January 22, 2018
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implicationHeike Bantel, Ali Canbay
Innere Medizin (Heidelberg, Germany)|May 8, 2024
[Drug treatment of non-alcoholic steatohepatitis : MAESTRO-NASH]Heike Bantel, Sirka Nitschmann
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can cell death biomarkers predict the outcome of acute liver failure?Heike Bantel, Klaus Schulze-Osthoff
Hepatology (Baltimore, Md.)|March 5, 2011
Necrosis versus apoptosis in acetaminophen-induced hepatotoxicityKlaus Schulze-Osthoff, Heike Bantel
Inflammatory Bowel Diseases|April 27, 2012
TNF Antagonists in IBD: Novel Antiinflammatory Mechanisms Beyond Cytokine InhibitionHeike Bantel, Klaus Schulze-Osthoff
Journal of Hepatology|August 25, 2022
Non-invasive tests for evaluating treatment response in NAFLDHeike Bantel, Klaus Schulze-Osthoff
The FEBS Journal|December 19, 2017
Macrophage p38 kinase inhibition for liver regenerationKlaus Schulze-Osthoff, Heike Bantel
Critical Care (London, England)|August 15, 2009
Cell death in sepsis: a matter of how, when, and whereHeike Bantel, Klaus Schulze-Osthoff
Frontiers in Physiology|April 10, 2012
Mechanisms of cell death in acute liver failureHeike Bantel, Klaus Schulze-Osthoff
Cell Cycle (Georgetown, Tex.)|August 3, 2010
DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondriaHeike Bantel, Hans-Uwe Simon
Pageof 11